ANTIANDROGEN

作品数:10被引量:50H指数:2
导出分析报告
相关领域:医药卫生生物学更多>>
相关期刊:《Acta Pharmacologica Sinica》《Asian Journal of Andrology》《Cell Research》《Cancer Drug Resistance》更多>>
相关基金:国家自然科学基金更多>>
-

检索结果分析

结果分析中...
选择条件:
  • 期刊=Asian Journal of Andrologyx
条 记 录,以下是1-5
视图:
排序:
Prior switching to a second-line nonsteroidal antiandrogen does not impact the therapeutic efficacy of abiraterone acetate in patients with metastatic castration-resistant prostate cancer: a real-world retrospective study被引量:3
《Asian Journal of Andrology》2018年第6期545-550,共6页Jin-G Zhao Jian-Dong Liu Peng-Fei Shen Xin Tang Guang-Xi Sun Xing-Ming Zhang Jun-Ru Chen Kun-Peng Shul Ming Shi Hao Zeng 
This work was supported by the National Natural Science Foundation of China (NSFC 81672547, 81402110, and 81272820); Science and Technology Support Program of Sichuan Province (2015SZ0142); and the 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University.
Even in the era of novel targeted agents, switching to a second-line nonsteroidal antiandrogen (NSAA) is still widely used in treating metastatic castration-resistant prostate cancer (mCRPC), especially in undevel...
关键词:ABIRATERONE ANTIANDROGEN castration-resistant prostate cancer FLUTAMIDE 
Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy
《Asian Journal of Andrology》2018年第5期432-437,共6页Yasutaka Yamada Shinichi Sakamoto Yoshiyasu Amiya Makoto Sasaki Takayuki Shima Akira Komiya Noriyuki Suzuki Koichiro Akakura Tomohiko Ichikawae Hiroomi Nakatsu 
The prognostic significance of initial prostate-specific antigen (PSA) level for metastatic prostate cancer remains uncertain. We investigated the differences in prognosis and response to hormonal therapies of metas...
关键词:alternative antiandrogen therapy antiandrogen withdrawal hormonal therapy metastatic prostate cancer PROSTATE-SPECIFICANTIGEN 
Intermittent, low-dose, antiandrogen monotherapy as an alternative therapeutic option for patients with positive surgical margins after radical prostatectomy被引量:1
《Asian Journal of Andrology》2018年第3期270-275,共6页Kyung Hwa Choi Seung Ryeol Lee Young Kwon Hong Dong Soo Park 
The aim of the present study was to determine whether oncologic outcomes and adverse events associated with active on/off intermittent antiandrogen monotherapy (daily bicalutamide, 50 mg per day) are comparable with...
关键词:androgen receptor antagonists disease progression margins of excision prostatectomy prostatic neoplasms 
Novel flutamide regulated genes in the rat veritral prostate: differential modulation of their expression by castration and flutamide treatments
《Asian Journal of Andrology》2007年第6期801-808,共8页Anil M Limaye Irfan Asangani Namrata Bora Paturu Kondaiah 
Aim: To identify flutamide regulated genes in the rat ventral prostate. Methods: Total RNA from ventral prostates of control and flutamide treated rats were isolated. Differentially expressed transcripts were identi...
关键词:ANDROGENS ANTIANDROGEN CASTRATION differential display reverse transcriptase polymerase chain reaction FLUTAMIDE PROSTATE 
Long-term effectiveness of luteinizing hormone-releasing hormone agonist or antiandrogen monotherapy in elderly men with localizect prostate cancer (T1-2) : a retrospective study被引量:1
《Asian Journal of Andrology》2007年第2期253-258,共6页Rupesh Raina Geetu Pahalajani Ashok Agarwal Craig Zippe 
Aim: To evaluate the long-term effectiveness, side effects and compliance rates of two types of drugs (luteinizing hormone-releasing hormone [LHRH] agonist and antiandrogen) that were used individually to treat pat...
关键词:localized prostate cancer ANTIANDROGEN prostate-specific antigen luteinizing hormone-releasing hormone agonist ANDROGEN ablation MONOTHERAPY 
检索报告 对象比较 聚类工具 使用帮助 返回顶部